Results 71 to 80 of about 83,570 (294)

Antibacterial efficacy of an ultra-short palmitoylated random peptide mixture in mouse models of infection by carbapenem-resistant Klebsiella pneumoniae [PDF]

open access: green, 2023
Jonathan Z. Lau   +10 more
openalex   +1 more source

Evaluation of FilmArray Multiplex PCR Test Results in Bloodstream Infections in Oncological Patients

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
In this study conducted at an oncology hospital, BCID2 panel results for the rapid identification of microorganisms and resistance genes in positive blood culture samples were compared with conventional culture methods. The BCID2 panel provided faster results and showed a high correlation with traditional methods.
İpek Mumcuoğlu   +6 more
wiley   +1 more source

Imipenem resistance in clinical Escherichia coli from Qom, Iran [PDF]

open access: yes, 2018
OBJECTIVE: The emergence of metallo-\u3b2-lactamase-producing Enterobacteriaceae is a worldwide health concern. In this study, the first evaluation of MBL genes, bla IMP and bla VIM , in Escherichia coli resistant to imipenem isolated from urine and ...
Esmkhani, M.   +5 more
core   +1 more source

Genomic Insights Into Carbapenem‐Resistant Klebsiella pneumoniae in Pediatric Bloodstream Infections in Zhejiang, China (2019–2024)

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
The primary mechanism of carbapenem resistance identified in pediatric CRKP‐BSI strains was the production of Class B metalloenzymes. We report, for the first time, an outbreak of bloodstream infections in a neonatal ward caused by the dissemination of NDM‐1‐producing ST25 K. pneumoniae.
Mingming Zhou   +8 more
wiley   +1 more source

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland

open access: yesBMC Infectious Diseases, 2018
Background We describe the prevalence of invasive carbapenem-resistant Acinetobacter spp. isolated from 2005 to 2016 in different regions of Switzerland.
A. Ramette   +2 more
doaj   +1 more source

Rising incidence of carbapenem resistant isolates: an Argentinian hospital’s experience. More trouble in the aftermath of the COVID-19 pandemic

open access: yesIberoamerican Journal of Medicine, 2022
Introduction: During COVID-19 outbreaks, disproportionate use of antibiotics, high Intensive Care Units burden and longer in-hospital stays may have aggravated the emergency posed by carbapenem-resistant isolates.
Maximiliano Gabriel Castro   +4 more
doaj   +1 more source

FAKTOR RISIKO DAN PENGARUH KLINIS INFEKSI CARBAPENEM-RESISTANT Acinetobacter sp. DI RSUP DR. KARIADI SEMARANG [PDF]

open access: yes, 2011
Background: Acinetobacter is one of negative gram bacteria which often contaminates and has already became an epidemic all over the world. The irrational use of carbapenem can caused Acinetobacter resistance.
Hapsari, Rebriarina   +2 more
core  

Chemical and antimicrobial analyses of Sideritis romana L. subsp. purpurea (Tal. ex Benth.) Heywood, an endemic of the Western Balkan [PDF]

open access: yes, 2017
A comprehensive study on essential oil and different solvent extracts of Sideritis romana L. subsp. purpurea (Tal. ex Benth.) Heywood (Lamiaceae) from Montenegro is reported. The gas chromatography-mass spectrometry analysis of the essential oil revealed
Božović, Mijat   +7 more
core   +1 more source

Glyco‐Nanogels for Modulating Pseudomonas aeruginosa Biofilm

open access: yesMacromolecular Rapid Communications, EarlyView.
Nanogels presenting α‐galactose and β‐fucose can significantly alter Pseudomonas aeruginosa biofilm dynamics through their interaction with lectins. Application timing is crucial: pre‐treatment reduces biofilm, while treatment after biofilm initiation increases biomass.
Sophia Rosencrantz   +4 more
wiley   +1 more source

Prevalence and Trends of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter Species Isolated from Clinical Specimens at the Ethiopian Public Health Institute, Addis Ababa, Ethiopia: A Retrospective Analysis

open access: yesInfection and Drug Resistance, 2023
Abera Abdeta,1 Abebe Aseffa Negeri,1 Degefu Beyene,1 Etsehiwot Adamu,1 Ebissa Fekede,1 Surafel Fentaw,1 Mheret Tesfaye,1 Getu Kusa Wakoya2 1National Clinical Bacteriology and Mycology Reference Laboratory, Ethiopian Public Health Institute, Addis Ababa ...
Abdeta A   +7 more
doaj  

Home - About - Disclaimer - Privacy